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SUMMARY
Dengue type 2 virus (DV)-induced suppressor cytokine (SF) binds to macrophages to transmit the
suppressor signal to recruit the second subpopulation of suppressor T cells. The present study was
undertaken to identify and purify the receptor for SF (SF-R) on macrophages. The binding of '251I-SF
to macrophages was saturable and reversible. Scatchard analysis showed the presence of both high
(54 000/cell) and low (1 -78 x 106/cell) affinity receptor sites. The binding of '251-SF to macrophages
was inhibited by pretreatment of macrophages with anti-SF antiserum but not by a heterologous
antiserum. Normal mouse peritoneal macrophage membrane was solubilized with Triton-X- 100 and
the components separated by low pressure liquid chromatography (LPLC) to purify SF-R. The
presence of SF binding moiety (SF-R) was screened at each step of purification. The purified SF-R
resolved into two bands of45-50 kD mol. wt on SDS-PAGE. '251-SF+ SF-R complex run on SDS-
PAGE showed a single band at about 55-60 kD mol. wt by autoradiography. Anti-SF-R antiserum
reacted with SF-R in a Western blot test; the reaction was abolished by pretreatment of the blots with
proteinase K, but not by pretreatment with periodic acid. SF-R was composed of two polypeptide
chains (a and P) which were obtained in pure form by high performance liquid chromatography
(HPLC) of dithiothreitol- and iodoacetamide-treated SF-R. Only the ,B chain bound SF.
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INTRODUCTION
Cascades of suppressor T cells consisting of sequential genera-
tions of two or more subpopulations of suppressor T cells have
been described in several models using synthetic antigens. These
cascades consist ofsuppressor T cells, their soluble products and
macrophages, the latter being essential for transmission of the
signal (reviewed in [1]). Recently, evidence has been presented
for suppressor T cells being a distinctive cell type and being
induced by suppressor determinants on the antigen [2]. Dengue
type 2 virus (DV) induces a suppressor pathway in mice
(reviewed in [3]) consisting of a subpopulation of suppressor
T cells (Tsl) in the spleen [4], which produce a soluble suppres-
sor cytokine (SF) [5]. The suppressor signal ofSF is transmitted
via syngeneic macrophages to recruit a second subpopulation of
suppressor T cells (Ts2) which produce another soluble, prosta-
glandin-like, suppressor cytokine (SF2) [6-8]. SF2 recruits the
third set of suppressor T cells (Ts3) which finally mediate
antigen-specific suppression of humoral immune response
[9,10]. SF is a low molecular weight, heat-labile, acid and
alkaline pH-labile, highly potent protein and acts in a dose-
dependent manner (reviewed in [3,11]).
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The presence of live macrophages is obligatory for the
transmission of the suppressor signal by SF between Tsl and
Ts2 both in vivo and in vitro [6,8]. Further, SF adsorbed on
macrophages remains at the surface and can be retrieved
completely by DV-stimulated spleen cells kept in contact with
them [12]. The present study was undertaken to identify and
purify the specific receptor for SF (SF-R) on macrophages.
MATERIALS AND METHODS
Animals
Inbred adult Swiss albino mice, aged 3-4 months, obtained from
the colony maintained in this Department were used.
Virus
Dengue type 2 virus (DV), strain P23085, was used in the form of
infected mouse brain suspension. The infectivity ofthe virus was
titrated by intracerebral (i.c.) inoculation in groups of mice as
described [13].
Preparation and purification ofSF
DV-induced SF was prepared by the technique described
previously [5]. Briefly, mice were inoculated intracerebrally with
1000 LD50 of DV. Spleens of infected mice were harvested
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8-11 days after inoculation and were homogenized in chilled
PBS pH 7-2. The homogenate was dialysed (cut off value of
membrane was 12 kD) against distilled water for 24 h with
constant shaking at 40C. The dialysed preparation of SF was
vacuum dried in a Speed Vac (Savant Instruments Inc., NY) and
stored at - 70'C. SF was purified by LKB Pharmacia high
performance liquid chromatography (HPLC) using reversed
phase super pac columns packed with silica gel C18. Elution was
performed with 20% methanol in water at a flow rate of 0 5 ml/
min and the elution fluid was monitored at 206 nm. The
chromatographic peaks were collected, vacuum dried, protein
content estimated [14] and stored at -70'C.
Radiolabelling ofSF
Radioiodination of SF was carried out using lactoperoxidase as
a catalyst [15,16]. SF (10 mg) was added to 1 mCi radiolabelled
iodine (1251) (Amersham, UK) in the presence of20 mm Tris-HCl
buffer pH 7-4, 50 pg lactoperoxidase and 0 1 mm cold sodium
iodide solution. The reaction was accelerated by addition of
0 8 mm H202 in five aliquots of 15 p1 each and terminated by
addition of /3-mercaptoethanol (final concentration of 10 mM).
Radioiodinated SF was dialysed against 2 mm sodium phos-
phate buffer pH 9. Radioactivity was measured in a LKB-mini
gamma counter. The biological activity of the radiolabelled SF
was not diminished when assessed for the suppressor activity.
Purity and molecular weight determination of the labelled SF
was performed by SDS-PAGE using 12 5% slab gels [17]
followed by autoradiography. The specific activity was calcu-
lated to be 9213 ct/min per nmole.
Preparation ofperitoneal macrophages
Heparinized Eagle's minimum essential medium (MEM) con-
taining 10% fetal calf serum (FCS) was inoculated into mice
intraperitoneally in doses of 5 ml and the peritoneal lavage was
aspirated onto a 5-cm glass Petri dish. After 2 h of incubation at
37°C in the presence of5% C02-air, the glass-non-adherent cells
were washed off and the glass-adherent macrophages were
gently scraped off with a rubber policeman. The cells were
suspended in normal saline and viable cells were counted using
exclusion of trypan blue dye.
Binding assay
Macrophages (1 x 106) were suspended in 500 p1 ofMEM with
10% FCS, pH 7 2. Various concentrations of '251-SF (0-005-
20 nM/ml) were added to the cells in the presence or absence of a
100-fold excess ofunlabelled SF to assess specific binding, with a
final incubation volume of 1000 pl in 18 ml Nunc cryotubes
(Nunc, Denmark). After incubation at 37°C for 1 h the cells
were centrifuged and the supernatant was aspirated. Radioacti-
vity ofthe cells was counted in a LKB-mini-gamma counter with
an efficiency of ca 60%. Non-specific binding, determined in the
presence of a 100-fold excess of unlabelled SF, was subtracted
from the total binding to give specific binding. Data from the
binding experiments were subjected to Scatchard analysis.
Detection of SF-R
The protocol for detection ofSF-R was based on the principle of
allowing SF to bind to the putative receptor at 37°C for 1 h. The
preparation was dialysed against an equal volume ofPBS at 4°C
overnight so that the unbound SF flowed out of the dialysis bag.
The suppressor activity of the dialysed and non-dialysable
portions was assayed by inhibition of DV-specific IgM antibody
plaque forming cells (PFC) in the spleen of mice [7]. The
presence of suppressor activity in the non-dialysable portion
was considered to indicate binding of SF, thereby showing
presence of SF-R.
Study of the structure of SF-R
The purified SF-R protein (5 pg in 0-5 ml) was incubated with
equal volume of 5 mm dithiothreitol (DTT; Sigma Chemical
Co., St Louis, MO) in the presence of 0 15 M Tris-HCl buffer
pH 8-0 for 45 min at room temperature. To this, I ml of 20 mm
iodoacetamide (Sigma) was added and incubated for 20 min at
room temperature. The preparation was analysed by HPLC as
described above.
Preparation of antisera
Antisera against SF-R were raised in mice by injecting 5 pg of
purified SF-R emulsified in Freund's complete adjuvant (FCA;
Sigma) intraperitoneally at the day 0, followed by a second dose
of 5 pg SF-R in Freund's incomplete adjuvant (FIA) intraperi-
toneally 15 days later. Blood was collected on day 30 and the
sera separated were pooled and stored at -20°C. A similar
protocol was used to prepare anti-SF antisera (SFAs) and anti-
helper cytokine-antisera (HFAs) [18]. The HFAs were used as
irrelevant antisera to study the specificity of the reaction with
SFAs.
PAGE and autoradiography
Electrophoresis was done on 12 5% PAGE or SDS-PAGE [17]
at constant current of 30 mA in a vertical slab gel system
(Pharmacia, Sweden). Gels were stained with silver nitrate [19]
or with coomassie brilliant blue R250 stain (Sigma). Some of the
gels were run along with molecular weight markers [20]. For
autoradiography the gels were vacuum dried (LKB slab gel
dryer) and exposed to Kodak x-ray film. The films were
developed after exposure for 15 days at -70°C.
Immunoblotting
Samples were resolved on 12 5% SDS-PAGE and electro-
blotted (Novablot Electrophoretic Transfer Kit, Pharmacia)
onto nitrocellulose paper. The blot was blocked overnight with
blocking buffer containing 3% bovine serum albumin (BSA) in
10 mm Tris-HCl, pH 7-4, followed by extensive washing with
PBS containing 0.05% Tween-20. The blots were incubated for
1 h with the anti-SF-R antisera at room temperature and after
three washings incubated with anti-mouse IgG horseradish
peroxidase conjugate for I h at room temperature. After
extensive washing, blots were developed using diaminobenzi-
dine and hydrogen peroxide [21]. For control, the blots were
treated with irrelevant antisera like anti-DV-antisera [22] and
HFAs. All chemicals and reagents used were purchased from
Sigma.
An effort was made to understand the chemical nature of the
antigen reactive in immunoblots. Before treatment with the
specific antibody, the blots were treated with proteinase K (5 pg/
ml) for 1 h at 370C or periodic acid (100 nM) in sodium acetate
buffer 50 nM, pH 4 6, followed by submersion in 1 M glycine in
PBS for 30 min in the dark [23]. A comparison with untreated
blot indicates the chemical nature of the antigen.
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Statistical analysis
Student's t-test was used for statistical analysis of the data. A P
value of less than 0-05 was considered significant.
RESULTS
The preparation containing '25I-SF was pooled and subse-
quently tested for purity by SDS-PAGE. The autoradiograph
of the pooled preparations presented in Fig. 1 shows presence of
a single band with an approximate mol. wt of 10 kD correspond-
ing to that of SF.
Saturation of binding
The saturability of binding of '25I-SF to macrophages was
examined. The data presented in Fig. 2a show that the binding
of SF increased in proportion to the amount of added labelled
material and the specific binding was saturated with 15 nM
'215I-SF. Scatchard analysis of the data was performed [24]. High
affinity receptors were detected on macrophages for SF when
binding assays were performed with low concentrations (0 005-
0 05 nM) of '251-SF while low affinity receptors were detected
with higher concentrations (0-5-20 nM). The high affinity
receptors showed an equilibrium dissociation constant (KD) of
0-0067 nm and the number of receptor sites was calculated as
54 000/cell (Fig. 2b). The low affinity receptors showed a larger
number of receptor sites, 1-78 x 106/cell, and a KD of 8-47 nM
(Fig. 2c). Conventional linear regression techniques were used
to calculate the line of best fit in the Scatchard plots (Fig. 2b, c).
Effect of anti-SF antisera on the binding of '25I-SF to
macrophages
The specificity of the binding of the radiolabelled SF to
macrophages was investigated using SFAs. For control a
heterologous antiserum (HFAs) was used. It was observed
(Fig. 3) that SFAs blocked the binding of 1251-SF to macro-
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Fig. 2. Specific binding of '251-suppressor cytokine (SF) to normal
mouse peritoneal macrophages. Macrophages (1 x 106) were incubated
with various concentrations of 1251I-SF for 60 min at 37 C. Non-specific
binding was measured in the presence of 100-fold excess of unlabelled
SF. The results are expressed as the amount of specifically bound SF in
nmoles/ 106 cells (a). Insets show Scatchard plot ofthe binding data from
(a) showing high affinity (b) and low affinity (c) receptors. Each point
was calculated by determining the moles of specifically bound (B) and
free (F) SF and plotting them as B/F versus B.
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Fig. 3. Effect of anti-suppressor cytokine (SF) antisera (SFAs) on the
binding of 1251-SF to macrophages. Macrophages (1 x 106) were treated
with 1:10 diluted SFAs or irrelevant antisera, the anti-HF antisera
(HFAs) for 1 h at 37 C. Specific binding was calculated by incubating
macrophages for 1 h at 37"C with 15 nM/ml 1251-SF in the presence or
absence of 100-fold excess of unlabelled SF. Data represent mean values
from two experiments. *, Control; 13, anti-HFAs; U, anti-SFAs.
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Fig. 1. Autoradiograph of 1251-suppressor cytokine (SF) analysed by
SDS-PAGE. The molecular mass (kD) of protein standards run on a
parallel gel are also indicated.
phages (74% inhibition) while HFAs had no significant effect
(5% inhibition).
Effects of various concentrations of unlabelled SF on specific
binding of '25I-SF to macrophages
The results presented in Fig. 4 show that excess concentration of
unlabelled SF was able to displace the bound '25I-SF to
macrophages in a dose-dependent manner.
Purification of SF-R from macrophages
Figure 5 presents the flow chart of the purification steps [25] of
SF-R. Normal mouse macrophages were sonicated for 2 min. A
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Fig. 4. Competition for the binding of 'I25I-suppressor cytokine (SF) to
macrophages by unlabelled SF. Macrophages (I x 106) were incubated
with various concentrations of unlabelled SF at 37 C for 1 h. The cells
were washed and further incubated with 15 nM/ml of '25I-SF for 1 h at
37TC and the radioactivity was counted.
drop of this preparation was examined under microscope to
confirm disruption of all the cells. The preparation was
centrifuged at 25 000 g for 90 min, the supernatant and pellet
were separately collected (A in Fig. 5) in an aliquot and were
assayed for binding with SF. It was observed that the pellet
bound the SF (61 % suppression; P< 0-001) while the super-
natant did not (Table 1, level A).
The pellet was suspended in PBS containing 1% Triton-X-
100 and sonicated for 5 min followed by stirring in cold for 2 h.
The preparation was centrifuged at 25 000 g for 30 min and the
supernatant and pellet were collected separately (B in Fig. 5). An
assay of the binding capacity revealed that the moiety present in
the supernatant bound SF (60% suppression, P< 0001) while
the pellet did not (Table 1, level B).
The supernatant was run on low pressure liquid chromato-
graphy (LPLC) using Sephacryl S-200 gel packed in 650 x 16
mm column with a bed height of 450 mm (Pharmacia). Elution
was performed with PBS at 40 cm3/h and the elution fluid was
monitored at 280 nm. Two chromatographic peaks were
obtained which were collected separately and freeze dried and
stored at -70 -C (C in Fig. 5). The findings presented in Table I,
level C, show that the protein eluted in peak 2 bound SF (59%/o
suppression, P<0 001) while that in peak 1 did not bind. At
every step of purification the original volume was made up and
the protein contents were estimated. The data summarized in
Table 2 show that in the final step of purification the specific
binding increased 14-fold.
PAGE of SF-R
The protein collected from the peak 2 of LPLC was freeze dried
and further investigated for purity and binding capacity. The
protein run on native PAGE yielded a single band, while under
reducing conditions on SDS-PAGE it resolved into two closely
Macrophage monolayer
Sonicate-2 min
Centrifuge-25 000 g for 90 min
I.A
Pellet suspend in PBS
Add Triton X-100 (1%)
Sonicat5 min
Stirred in cold-2 h
I
Centrifuge-25 000 g for 30 min
I.B
Supernate
I
Run on LPLC
Peak 1 Peak 2
+SF +SF
1 h at 37'C
I. c
Dialysed for 24 h
Dialysate Non-dialysate Dialysate Non-dialysate
IF
Assayed for suppressor activity
Fig. 5. Flow chart of the purification steps of the receptors for
suppressor cytokine (SF-R) on macrophages.
placed bands corresponding to a position of 45-50 kD mol. wt
(Fig. 6a). To identify the band which could bind SF, the gel was
incubated with '25I-SF at 370C for 2 h, extensively washed, cut
into slices and counted for radioactivity. The radioactivity was
present mainly in the eighth fraction of the gel, ct/min being
1204 per slice of the gel. This fraction of the gel corresponded
with the band at 45-50 kD position of the silver-stained gel.
The capacity of the purified peak 2 protein to bind SF was
further investigated. The protein was mixed with '251-SF and
incubated at 37°C for 2 h and was then run on the native PAGE
followed by autoradiography. It showed a single band (Fig. 6b).
A similar run on SDS-PAGE showed a single band at 55-60 kD
position of the SF (10 kD mol. wt)+ SF-R (45-50 kD) complex
(Fig. 6c).
Immunoblotting
The specificity of the binding protein was confirmed by
immunoblotting. The findings presented in Fig. 6d show that the
anti-SF-R antisera reacted with both the bands resolved on
SDS-PAGE. No reaction was observed with normal mouse sera
or irrelevant antisera (HFAs and anti-DV antisera). Pretreat-
260
Receptor on macrophages for the dengue virus-induced suppressor cytokine
Table 1. Assay for the presence of suppressor cytokine
receptor (SF-R) in different preparations during the
course of purification
No. of PFC/2 x 106 Per cent
Groups cells suppression
Level A
Supernatant
Non-dialysed 443 + 36 11
Dialysed 204 +28 59
Pellet
Non-dialysed 199 +27 60*
Dialysed 408 + 19 18*
Level B
Supernatant
Non-dialysed 200 + 37 60*
Dialysed 428 +47 15*
Pellet
Non-dialysed 470 + 38 6
Dialysed 277 + 38 44
Level C
Peak I
Non-dialysed 446 + 36 11
Dialysed 229 + 15 54
Peak 2
Non-dialysed 217+24 57*
Dialysed 462+33 7*
SF alone 207 + 34 59
Control (DV alone) 498 + 22 0
To detect the presence of SF-R, each preparation at
different levels of purification (as shown in Fig. 5) was
treated with SF followed by dialysis to remove the
unbound SF. Then the suppressor activity of the
dialysed and non-dialysed fractions was assayed. Pres-
ence of suppressor activity in non-dialysed part indi-
cated existence of SF-R (*P<0.001). At each step the
original volume was maintained. For the assay of
suppressor activity mice were primed with 1000 LD50 Of
dengue type 2 virus (DV) intraperitoneally followed 48 h
later with the i.v. inoculation of the test fraction. IgM
plaque-forming cells (PFC) were counted in the spleen
on the sixth day after DV inoculation and the findings
were compared with those in control mice given only
DV intraperitoneally after deducting the background
value in normal mice. The suppression was calculated as
follows:
Suppression (%)
100_ PFC in test -background value x 100
PFC in control-background value
Each group consisted of six-to-eight mice and from
each mouse spleen four-to-six smears were prepared.
The mean value + s.d. has been presented.
ment of the blots with proteinase K abolished the immunoblot
reaction while treatment with periodic acid had no effect.
SF-R has two polypeptide chains
This experiment was done to discover the structure of SF-R
protein molecule. The findings presented in Fig. 7 show that
DTT- and iodoacetamide-treated SF-R protein resolved into
Table 2. Protein concentration and scaling up of the binding capacity at
different steps of purification
Amount of Increase in
Purification protein binding of
steps Samples (pg/I00 p1) SF
Starting material Total sonicate 162 5
Level
A Supernatant 75
Pellet 83 3 1 95-fold
B Supernatant 60 8 2-67-fold
Pellet 28 3
C Peak I 10
Peak 2 11-6 14-fold
At different steps of purification of suppressor cytokine receptor
(SF-R) (see Fig. 5) protein contents of different preparations were
estimated, keeping volumes of all the preparations exactly the same as
the starting material. Increase in the binding capacity was calculated in
terms of reduction in the amount of protein required for the similar per
cent of suppressor activity.
two peaks, the first termed a and the second /3 chain. Both the
chains were incubated separately with SF and then dialysed
overnight. The dialysate and non-dialysate of both the chains
were assayed for suppressor activity. The results presented in
Table 3 show that the ae chain of SF-R did not bind SF (14%
suppression), while the # chain of SF-R bound SF (56%
suppression).
DISCUSSION
The results of the experiments reported here establish the
presence of a receptor, specific for DV-induced SF on mouse
peritoneal macrophages. It has been observed that macrophages
are obligatory for the transmission of suppressor signal by SF to
Ts2 cells in DV-induced suppressor pathway [6,8]. A crucial role
of macrophages in the transmission of suppressor [26,27] and
helper [28] signal has been reported in other models also. The
present study may indicate that uptake of SF by macrophages
and subsequent presentation of the signal to the T lymphocytes
is mediated by the presence of SF-specific cell surface receptors
on macrophages.
The interaction between SF and the receptor was specific as
it fulfilled all the criteria [29] of a specific peptide-receptor
interaction. It was observed that the binding approached
saturation at a concentration of 15 nm of labelled SF; the
binding was displaced with excess unlabelled SF and was
reversible. Further, the binding was pH-, time- and tempera-
ture-dependent (Mukherjee et al., unpublished data). Scatchard
analysis of the binding data revealed the presence of both high
(54 000/cell) and low (1 78 x 106/cell) affinity receptor sites. This
analysis indicated that interaction of SF with its receptors fits
with a bimolecular association of the peptide and a population
of non-interacting receptor sites. This is consistent with disso-
ciation experiments which indicate simple first-order kinetics.
That the binding was specific, was further supported by the
finding of a marked inhibition of the binding by pretreatment
with SFAs but not by a heterologous antisera (HFAs) and
affinity cross-linking experiments (unpublished data). The find-
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Fig. 6. PAGE and autoradiography of purified suppressor cytokine receptor (SF-R). (a) SDS-PAGE of purified SF-R along with the
mol. wt marker proteins. Autoradiogram of 1251-SF+ SF-R complex on (b) native PAGE and (c) SDS-PAGE. (d) Western blot analysis
was done by transfer of protein from SDS-PAGE. A, Treated with anti-SF-R antisera; B, anti-dengue type 2 virus (DV) antisera; C,
proteinase K; D, periodic acid.
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Fig. 7. High performance liquid chromatography (HPLC) elution
profile of suppressor cytokine receptor (SF-R) treated with dithiothrei-
tol (DTT) and iodoacetamide. Peak 1 was termed as a and peak 2 as
j3 chain.
Table 3. Binding of suppressor cytokine (SF) to the
polypeptide chains of SF-R
No. of PFC/2 x 106 Per cent
Groups cells suppression
a-chain SF
non-dialysed 465 + 32 14
dialysed 222 + 23 59
#-chain SF
non-dialysed 241 + 22 56
dialysed 481+33 1 1
SF 228++20 58
Control 542 +42 0
Purified SF-R was treated with dithiothreitol
and then with iodoacetamide to cleave the S-S
linkage between the two polypeptide chains. The
preparation was resolved on high performance
liquid chromatography (HPLC) and peak 1 (a
chain) and peak 2 (/3 chain) as shown in Fig. 7 was
assayed for the capacity to bind SF as described in
Table 1. When SF binds to SF-R chain, it does not
move out of the dialysis bag. All the details
including the number ofmice are as in Table 1. PFC,
Plaque-forming cells.
ings, thus, present evidence of a specific receptor for SF on
macrophages. In preliminary experiments some such receptor
sites were found on T and B cells ofmouse spleen (Mukherjee et
al., unpublished data). The purified SF-R had the capacity to
bind SF, as shown by the presence of suppressor activity in
SF+ SF-R complex and demonstration of binding of '25I-SF to
SF-R by autoradiography of the complex. This is further
supported by the findings of affinity cross-linking experiments
(unpublished data).
Cytokines transmit the signal by binding to specific sites on
cell membrane, the receptor molecules. The receptors dis-
tinguish and receive the specific signal and relay it in such a way
that an appropriate cellular response follows. The binding of
cytokines to the receptor may be of high, low or intermediate
affinity. IL-2 has high, low and intermediate affinity receptors
[30-35]. Both high and low affinity receptors have been reported
for IL-5 [36,37] and IL-7 [38]. While the receptors for IL-3 are
only of low affinity [39], those for GM-CSF and M-CSF [40] are
only of high affinity.
Purified SF-R resolved as a single band on native PAGE but
was split into two closely placed bands of 45-50 kD on SDS-
PAGE. Both the bands reacted equally well in a Western blot
test with anti-SF-R antisera. Pretreatment of the blot with
proteinase K abolished the Western blot reaction, while treat-
ment with periodic acid had no effect. This indicated that the
antigenic site on SF-R was protein in nature.
The receptors for various cytokines have been shown to be
composed of a single polypeptide chain, for example the
receptors for G-CSF [41] and M-CSF [40]; while the receptors
for IL-1 [42] and IL-8 [43] have two polypeptide chains. The
receptor for IL-2 is composed of two non-covalently linked
chains (a and chains) forming high affinity binding sites; the
chain has no biological role except to cooperate with the
a chain to make high affinity sites [44,45]. The SF-R was shown
to be composed of two polypeptide chains (ax and fl) coupled by
disulphide linkages and only the chain was capable of binding
SF, as shown by (i) the biological activity ofSF (the SF bound to
the SF-R chain did not move out of the dialysis bag), and (ii) the
autoradiography following SDS-PAGE analysis of 125I-
SF+ SF-R complex which showed binding to only one of the
two bands (P 50) of SF-R. Presence of a second membrane-
bound protein which complexes with the primary receptor to
form high affinity binding sites has also been shown in IL-3, IL-6
and GM-CSF, which indicates that a receptor-ligand complex
lacking intracellular sequences can interact with other cell
surface molecules to transduce signals into cells (reviewed in
[46]). Using the model of natural killer cell stimulatory factor
(NKSF), a disulphide-linked heterodimer, it has been suggested
that the regulation of cell growth and differentiation could be
provided by variable combination of subunits in a receptor-
ligand complex [46].
SF is composed of two polypeptide chains linked by
disulphide bonds [47] and its a chain binds to the SF-R and the P
chain (of SF) to H-2A gene product on macrophage membrane
(Mukherjee et al., manuscript in preparation). SF has both high
and low affinity receptor sites on macrophages. It is not yet
known whether the SF-R, purified in the present study, is
responsible for high or low affinity binding and what factors
determine it. Studies are underway to answer these questions
and analyse the sequence of the SF-R to determine its homology
to other cytokine receptors.
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